Template:Mefloquine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
__NOTOC__
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{{Mefloquine}}
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Mefloquine|{{fontcolor|#6C7B8B|Mefloquine}}]]'''''
{{CMG}}; {{AE}} {{chetan}}
|-
 
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |MEFLOQUINE HYDROCHLORIDE<sup>®</sup> FDA Package Insert
==Overview==
|-
'''Mefloquine''' hydrochloride (Lariam, Mephaquin or Mefliam) is an orally administered [[antimalarial drug|medication]] used in the prevention and treatment of [[malaria]].  Mefloquine was developed in the 1970s at the [[United States Department of Defense]]'s [[Walter Reed Army Institute of Research]] as a synthetic analogue of [[quinine]].  The brand name drug, Lariam, is manufactured by the Swiss company [[Hoffmann–La Roche]].  In August 2009, Roche stopped marketing Lariam in the United States.  Generic mefloquine from other manufacturers is still widely available. Rare but serious neuropsychiatric problems have been associated with its use.<ref name=":0">Thomas, Katie.  "F. D. A. Strengthens Warnings on Lariam, an Anti-Malarial Drug."  ''The New York Times''. July 29, 2013.</ref>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine description|Description]]
==Category==
|-
Antimalarial
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine clinical pharmacology|Clinical Pharmacology]]
==US Brand Names==
|-
MEFLOQUINE HYDROCHLORIDE<sup>®</sup>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine microbiology|Microbiology]]
==FDA Package Insert==
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine indications and usage|Indications and Usage]]
'''  [[Mefloquine description|Description]]'''
|-
'''| [[Mefloquine clinical pharmacology|Clinical Pharmacology]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine contraindications|Contraindications]]
'''| [[Mefloquine microbiology|Microbiology]]'''
|-
'''| [[Mefloquine indications and usage|Indications and Usage]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine warnings and precautions|Warnings and Precautions]]
'''| [[Mefloquine contraindications|Contraindications]]'''
|-
'''| [[Mefloquine warnings and precautions|Warnings and Precautions]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine adverse reactions|Adverse Reactions]]
'''| [[Mefloquine adverse reactions|Adverse Reactions]]'''
|-
'''| [[Mefloquine drug interactions|Drug Interactions]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine drug interactions|Drug Interactions]]
'''| [[Mefloquine overdosage|Overdosage]]'''
|-
'''| [[Mefloquine clinical studies|Clinical Studies]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine overdosage|Overdosage]]
'''| [[Mefloquine dosage and administration|Dosage and Administration]]'''
|-
'''| [[Mefloquine how supplied|How Supplied]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine dosage and administration|Dosage and Administration]]
'''| [[Mefloquine labels and packages|Labels and Packages]]'''
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine how supplied|How Supplied]]
==Mechanism of Action==
|-
The exact mechanism of action is uncertain. However, it is proposed to share a similar mechanism of action with chloroquine, which is inhibition of heme polymerase.
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Mefloquine labels and packages|Labels and Packages]]
 
|-
==References==
|}
{{Reflist|2}}
 
[[Category:Antibiotics]]
[[Category:Wikinfect]]

Latest revision as of 00:55, 8 January 2014